Citation tools
"Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of 177Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?." Journal of Nuclear Medicine Technology
50.3
(2022):
248-255.
Web. 19 April. 2025.